Is GoHealth Stock a Good Investment?
GoHealth Investment Advice | GOCO |
- Examine GoHealth's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research GoHealth's leadership team and their track record. Good management can help GoHealth navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Property & Casualty Insurance space and any emerging trends that could impact GoHealth's business and its evolving consumer preferences.
- Compare GoHealth's performance and market position to its competitors. Analyze how GoHealth is positioned in terms of product offerings, innovation, and market share.
- Check if GoHealth pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about GoHealth's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in GoHealth stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if GoHealth is a good investment.
Sell | Buy |
Sell
Market Performance | Insignificant | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine GoHealth Stock
Researching GoHealth's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 14.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.58. Some equities with similar Price to Book (P/B) outperform the market in the long run. GoHealth recorded a loss per share of 0.66. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 18th of November 2022.
To determine if GoHealth is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GoHealth's research are outlined below:
| GoHealth had very high historical volatility over the last 90 days | |
| GoHealth has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 798.89 M. Net Loss for the year was (7.32 M) with profit before overhead, payroll, taxes, and interest of 668.28 M. | |
| GoHealth currently holds about 215.4 M in cash with (21.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 24.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| GoHealth has a frail financial position based on the latest SEC disclosures | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from zacks.com: Acquisition by Cb Blizzard Holdings C, L.p. of 11102 shares of GoHealth at 14.0348 subject to Rule 16b-3 |
GoHealth Quarterly Liabilities And Stockholders Equity |
|
GoHealth uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in GoHealth. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GoHealth's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
GoHealth Target Price Consensus
GoHealth target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. GoHealth's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most GoHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand GoHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of GoHealth, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGoHealth Target Price Projection
GoHealth's current and average target prices are 13.79 and 19.50, respectively. The current price of GoHealth is the price at which GoHealth is currently trading. On the other hand, GoHealth's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On GoHealth Target Price
GoHealth Analyst Ratings
GoHealth's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about GoHealth stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of GoHealth's financials, market performance, and future outlook by experienced professionals. GoHealth's historical ratings below, therefore, can serve as a valuable tool for investors.Know GoHealth's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as GoHealth is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GoHealth backward and forwards among themselves. GoHealth's institutional investor refers to the entity that pools money to purchase GoHealth's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-12-31 | 48.4 K | Ancora Advisors Llc | 2024-12-31 | 30.5 K | Ameriprise Financial Inc | 2024-12-31 | 28.8 K | Bridgeway Capital Management, Llc | 2024-12-31 | 23.2 K | Empowered Funds, Llc | 2024-12-31 | 23.2 K | Renaissance Technologies Corp | 2024-12-31 | 22.6 K | Acadian Asset Management Llc | 2024-12-31 | 21.1 K | Jpmorgan Chase & Co | 2024-12-31 | 17.2 K | Goldman Sachs Group Inc | 2024-12-31 | 16.2 K | Centerbridge Partners, L.p. | 2024-12-31 | 4.2 M | Blackrock Inc | 2024-12-31 | 308.3 K |
GoHealth's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 313.42 M.Market Cap |
|
GoHealth's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Determining GoHealth's profitability involves analyzing its financial statements and using various financial metrics to determine if GoHealth is a good buy. For example, gross profit margin measures GoHealth's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GoHealth's profitability and make more informed investment decisions.
Evaluate GoHealth's management efficiency
As of the 20th of March 2025, Return On Tangible Assets is likely to drop to -0.0026. In addition to that, Return On Capital Employed is likely to drop to -0.0064. At this time, GoHealth's Total Assets are very stable compared to the past year. As of the 20th of March 2025, Non Current Assets Total is likely to grow to about 1.3 B, while Net Tangible Assets are likely to drop (220.4 M). GoHealth's management efficiency ratios could be used to measure how well GoHealth manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 45.93 | 43.64 | |
| Tangible Book Value Per Share | 15.62 | 16.40 | |
| Enterprise Value Over EBITDA | 3.57 | 3.39 | |
| Price Book Value Ratio | 0.45 | 0.48 | |
| Enterprise Value Multiple | 3.57 | 3.39 | |
| Price Fair Value | 0.45 | 0.48 | |
| Enterprise Value | 1.2 B | 1.1 B |
GoHealth showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta 1.679 |
Basic technical analysis of GoHealth Stock
As of the 20th of March, GoHealth retains the Market Risk Adjusted Performance of 1.68, risk adjusted performance of 0.0639, and Semi Deviation of 4.34. GoHealth technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.GoHealth's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GoHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on GoHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GoHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GoHealth's Outstanding Corporate Bonds
GoHealth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GoHealth uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GoHealth bonds can be classified according to their maturity, which is the date when GoHealth has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand GoHealth's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing GoHealth's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0639 | |||
| Market Risk Adjusted Performance | 1.68 | |||
| Mean Deviation | 3.91 | |||
| Semi Deviation | 4.34 | |||
| Downside Deviation | 4.59 | |||
| Coefficient Of Variation | 1586.6 | |||
| Standard Deviation | 5.7 | |||
| Variance | 32.44 | |||
| Information Ratio | 0.0783 | |||
| Jensen Alpha | 0.3692 | |||
| Total Risk Alpha | 0.976 | |||
| Sortino Ratio | 0.0972 | |||
| Treynor Ratio | 1.67 | |||
| Maximum Drawdown | 33.97 | |||
| Value At Risk | (5.80) | |||
| Potential Upside | 9.61 | |||
| Downside Variance | 21.05 | |||
| Semi Variance | 18.88 | |||
| Expected Short fall | (4.39) | |||
| Skewness | 1.15 | |||
| Kurtosis | 3.13 |
| Risk Adjusted Performance | 0.0639 | |||
| Market Risk Adjusted Performance | 1.68 | |||
| Mean Deviation | 3.91 | |||
| Semi Deviation | 4.34 | |||
| Downside Deviation | 4.59 | |||
| Coefficient Of Variation | 1586.6 | |||
| Standard Deviation | 5.7 | |||
| Variance | 32.44 | |||
| Information Ratio | 0.0783 | |||
| Jensen Alpha | 0.3692 | |||
| Total Risk Alpha | 0.976 | |||
| Sortino Ratio | 0.0972 | |||
| Treynor Ratio | 1.67 | |||
| Maximum Drawdown | 33.97 | |||
| Value At Risk | (5.80) | |||
| Potential Upside | 9.61 | |||
| Downside Variance | 21.05 | |||
| Semi Variance | 18.88 | |||
| Expected Short fall | (4.39) | |||
| Skewness | 1.15 | |||
| Kurtosis | 3.13 |
Consider GoHealth's intraday indicators
GoHealth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GoHealth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
GoHealth Corporate Filings
| 6th of March 2025 Other Reports | ViewVerify | |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 23rd of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
GoHealth Stock media impact
Far too much social signal, news, headlines, and media speculation about GoHealth that are available to investors today. That information is available publicly through GoHealth media outlets and privately through word of mouth or via GoHealth internal channels. However, regardless of the origin, that massive amount of GoHealth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of GoHealth news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of GoHealth relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to GoHealth's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive GoHealth alpha.
GoHealth Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards GoHealth can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
GoHealth Corporate Management
| Michael Kelley | Chief Insights | Profile | |
| Melissa Balsan | Chief Officer | Profile | |
| Michael Hargis | Chief Officer | Profile | |
| Shane Cruz | Chief Officer | Profile | |
| Blair Kessler | Chief Officer | Profile | |
| Jason Schulz | Executive Officer | Profile | |
| Stephen Moffat | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.241 | Earnings Share (0.66) | Revenue Per Share | Quarterly Revenue Growth 0.406 | Return On Assets |
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between GoHealth's value and its price, as these two are different measures arrived at by various means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.